CRADLE-4: Can Reduction of Adverse pregnancy outcomes occur with planned DeLivery vs.Expectant management in pre-eclampsia?
CRADLE-4:先兆子痫的计划分娩与期待治疗能否减少不良妊娠结局?
基本信息
- 批准号:MR/R021376/1
- 负责人:
- 金额:$ 105.18万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Research Grant
- 财政年份:2018
- 资助国家:英国
- 起止时间:2018 至 无数据
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Pre-eclampsia affects approximately one in twenty-five pregnancies and is diagnosed by doctors when the mother develops high blood pressure and protein in her urine. The complications of this disorder are potentially very serious. Pre-eclampsia, particularly when it occurs early on in pregnancy, can result in severe problems for the mother such as fits, bleeding, and may even result in her death. The baby can be affected by a poorly functioning placenta, which leads to reduced blood flow, inadequate nutrition and poor oxygen supply which can result in reduced growth so that the infant may be born with a low birthweight and may even die. Death of the baby is common when the disease is not recognized in a timely fashion, common in a LMIC setting. Timely delivery of the baby will prevent many of these complications, but can also increase the risk of problems for the baby related to premature birth and immaturity.In women who develop raised blood pressure or mild pre-eclampsia at the end of pregnancy, bringing on labour has been shown to reduce the risk of problems to the mother and also lower the caesarean section rate, without any increased risk to the baby. When pre-eclampsia occurs in early pregnancy, before the 34th week of pregnancy, the risk to the baby of being born early is high. In this case it is better not to deliver unless the mother or baby deteriorate. The risk/benefit of routinely delivering the baby between the 34th and 37th week of pregnancy is less clear. Approximately a third of women with pre-eclampsia present in this window, and the disease in more severe than at term. Delivery may prevent complications in the mother but might increase risks to the baby compared with delivery at term. This decision is even more complicated when women live in countries with less resources where there are fewer doctors, midwives, nurses, medical supplies and hospital beds and different cultural values. In this trial we would aim to determine whether recognition and accurate diagnosis with delivery (bringing on labour within 48 hours or caesarean) or 'watch and wait' management is better for women with pre-eclampsia living in India and Zambia between the 34th and 37th week of pregnancy and their babies. 'Watch and wait', which medical professionals call 'expectant management', means that pregnant women will be closely observed and only be delivered if any complications arise in either the mother or the baby, or if the 37th week of pregnancy is reached. To test this, pregnant women that have been diagnosed with pre-eclampsia using our CRADLE VSA device, who come into hospital or clinic between the 34th and 37th week of pregnancy but do not require immediate delivery, will be allocated by a computer (i.e. by chance, like tossing a coin) to delivery or expectant management. If they are allocated to delivery they may have to travel to a local hospital where they have the facilities for this. If they are allocated to expectant management they will continue to have the same care they would usually have had. This may include staying in hospital for observation or coming to clinic for regular check ups. We will find out if there are fewer complications in the mother if we adopt the policy of immediate delivery. The study will also find out if this strategy leads to fewer babies being admitted to hospital, less frequent admission to a baby intensive care unit and if there are fewer deaths in this group when compared to those babies born to women in the 'wait and watch' group.We have chosen to run this trial in India and Zambia as they have different health care systems and challenges. We will ensure we find out about how the strategy is affected in each country and about the experiences of women and their families so our results will be relevant to many other countries.
先兆子痫影响大约二十五分之一的孕妇,当母亲出现高血压和尿中蛋白质时,医生会诊断出先兆子痫。这种疾病的并发症可能非常严重。先兆子痫,特别是当它发生在怀孕早期,可能会导致严重的问题,为母亲,如适合,出血,甚至可能导致她的死亡。婴儿可能会受到胎盘功能不良的影响,这会导致血流减少,营养不足和氧气供应不足,从而导致生长减缓,因此婴儿可能出生时体重不足,甚至可能死亡。婴儿死亡是常见的,当疾病没有及时识别时,常见于LMIC环境中。及时分娩可以预防许多并发症,但也会增加婴儿早产和不成熟的风险。对于那些在怀孕结束时出现血压升高或轻度先兆子痫的妇女,分娩已被证明可以降低母亲出现问题的风险,也可以降低剖腹产率,而不会增加婴儿的风险。当先兆子痫发生在怀孕早期,在怀孕的第34周之前,婴儿早产的风险很高。在这种情况下,最好不要分娩,除非母亲或婴儿恶化。在怀孕第34周到第37周之间常规分娩婴儿的风险/益处尚不清楚。大约三分之一的先兆子痫妇女出现在这个窗口期,并且疾病比足月时更严重。分娩可以预防母亲的并发症,但与足月分娩相比,可能会增加婴儿的风险。如果妇女生活在资源较少的国家,那里的医生、助产士、护士、医疗用品和医院病床较少,而且文化价值观不同,这一决定就更加复杂。在这项试验中,我们的目标是确定识别和准确诊断与分娩(在48小时内分娩或剖腹产)或“观察和等待”管理是否对生活在印度和赞比亚的妊娠第34周至第37周的先兆子痫妇女及其婴儿更好。“观察和等待”,医学专业人士称之为“期待管理”,意味着孕妇将被密切观察,只有在母亲或婴儿出现任何并发症,或者怀孕达到第37周时才能分娩。为了测试这一点,使用我们的CRADLE VSA设备诊断为先兆子痫的孕妇,在怀孕第34周至第37周之间进入医院或诊所,但不需要立即分娩,将由计算机分配(即随机分配,就像扔硬币一样)到分娩或期待管理。如果她们被分配分娩,她们可能不得不前往当地医院,那里有分娩设施。如果他们被分配到预期管理,他们将继续得到同样的照顾,他们通常会有。这可能包括留院观察或到诊所进行定期检查。如果我们采取立即分娩的政策,我们将发现母亲的并发症是否减少。这项研究还将发现这种策略是否会导致更少的婴儿入院,更少的婴儿重症监护室入院,以及与“等待和观察”组的妇女所生的婴儿相比,这组婴儿的死亡率是否更低。我们选择在印度和赞比亚进行这项试验,因为他们有不同的医疗保健系统和挑战。我们将确保了解该战略在每个国家的影响以及妇女及其家庭的经历,以便我们的结果与许多其他国家相关。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Additional file 1 of Planned early delivery for late preterm pre-eclampsia in a low- and middle-income setting: a feasibility study
低收入和中等收入环境中晚期早产先兆子痫的计划提前分娩的附加文件 1:可行性研究
- DOI:10.6084/m9.figshare.14721804
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Beardmore-Gray A
- 通讯作者:Beardmore-Gray A
Additional file 3 of Planned early delivery for late preterm pre-eclampsia in a low- and middle-income setting: a feasibility study
附加文件 3:中低收入环境中晚期早产先兆子痫的计划提前分娩:可行性研究
- DOI:10.6084/m9.figshare.14721813
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Beardmore-Gray A
- 通讯作者:Beardmore-Gray A
Planned early delivery for late preterm pre-eclampsia in a low- and middle-income setting: a feasibility study.
- DOI:10.1186/s12978-021-01159-y
- 发表时间:2021-06-02
- 期刊:
- 影响因子:3.4
- 作者:Beardmore-Gray A;Vousden N;Silverio SA;Charantimath U;Katageri G;Bellad M;Chinkoyo S;Vwalika B;Goudar S;Sandall J;Chappell LC;Shennan AH
- 通讯作者:Shennan AH
Planned early delivery versus expectant management to reduce adverse pregnancy outcomes in pre-eclampsia in a low- and middle-income setting: study protocol for a randomised controlled trial (CRADLE-4 Trial).
- DOI:10.1186/s13063-020-04888-w
- 发表时间:2020-11-23
- 期刊:
- 影响因子:2.5
- 作者:Beardmore-Gray A;Vousden N;Charantimath U;Katageri G;Bellad M;Kapembwa K;Chinkoyo S;Vwalika B;Clark M;Hunter R;Seed P;Goudar S;Chappell LC;Shennan A
- 通讯作者:Shennan A
Additional file 2 of Planned early delivery for late preterm pre-eclampsia in a low- and middle-income setting: a feasibility study
低收入和中等收入环境中晚期早产先兆子痫的计划提前分娩的附加文件 2:可行性研究
- DOI:10.6084/m9.figshare.14721810
- 发表时间:2021
- 期刊:
- 影响因子:0
- 作者:Beardmore-Gray A
- 通讯作者:Beardmore-Gray A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Shennan其他文献
PP058. Cradle: Community blood pressure monitoring in rural Africa: Detection of underlying pre-eclampsia
- DOI:
10.1016/j.preghy.2013.04.085 - 发表时间:
2013-04-01 - 期刊:
- 影响因子:
- 作者:
Natasha Hezelgrave;Annemarie de Greef;Lucy Irvine;Paul Seed;Samara Radford;Andrew Shennan - 通讯作者:
Andrew Shennan
OP 35 Incidence of pre-eclampsia in the UK in 2016–17
- DOI:
10.1016/j.preghy.2017.07.058 - 发表时间:
2017-07-01 - 期刊:
- 影响因子:
- 作者:
Eleanor Hendy;Nicola Vousden;Andrew Shennan;Lucy Chappell - 通讯作者:
Lucy Chappell
Evidence for Intrauterine Infection with Ureaplasma Urealyticum (UU) as a Major Cause of Preterm Birth
- DOI:
10.1203/00006450-199904020-01594 - 发表时间:
1999-04-01 - 期刊:
- 影响因子:3.100
- 作者:
Michael Dunn;Anne Matlow;Joseph Stiskal;Karel O'Brien;Danuta Kovach;Lesley Wylie;Cecelia Th'ng;Edmond Kelly;Andrew Shennan;Marlene Rabinovitch;Patricia Quinn - 通讯作者:
Patricia Quinn
OP 2 Placental growth factor informed management of suspected pre-eclampsia and/or fetal growth restriction – The MAPPLE cohort study
- DOI:
10.1016/j.preghy.2017.07.025 - 发表时间:
2017-07-01 - 期刊:
- 影响因子:
- 作者:
Andrew Sharp;Lucy Chappell;Gustaaf Dekker;Sanja Pelletier;Yves Garnier;Onur Zeren;Katharina M. Hillerer;Thorsten Fischer;Paul Seed;Mark Turner;Andrew Shennan;Zarko Alfirevic - 通讯作者:
Zarko Alfirevic
OP 17 Performance of commercially available placental growth factor kits in women with suspected or confirmed pre-eclampsia
- DOI:
10.1016/j.preghy.2017.07.040 - 发表时间:
2017-07-01 - 期刊:
- 影响因子:
- 作者:
Fergus McCarthy;Carolyn Gill;Paul Seed;Kate Bramham;Lucy Chappell;Andrew Shennan - 通讯作者:
Andrew Shennan
Andrew Shennan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Shennan', 18)}}的其他基金
SIPHRE Shock Index in Pregnancy: Haemorrhage Risk Evaluation. Shock index as a predictor of adverse outcome in maternal haemorrhage
SIPHRE 妊娠期休克指数:出血风险评估。
- 批准号:
MR/T038942/1 - 财政年份:2021
- 资助金额:
$ 105.18万 - 项目类别:
Research Grant
The HAPPEE Partnership Project (Humanities and Arts in Preventing Pre-eclampsia complications through community Engagement and Education)
HAPPEE 合作伙伴项目(通过社区参与和教育预防先兆子痫并发症的人文和艺术)
- 批准号:
MC_PC_MR/R024510/1 - 财政年份:2018
- 资助金额:
$ 105.18万 - 项目类别:
Research Grant
Evaluation of the introduction of a novel device in the management of hypertension and shock in pregnancy in low-resource settings
在资源匮乏地区引入新型设备治疗妊娠期高血压和休克的评估
- 批准号:
MR/N006240/1 - 财政年份:2015
- 资助金额:
$ 105.18万 - 项目类别:
Research Grant
相似国自然基金
兼捕减少装置(Bycatch Reduction Devices, BRD)对拖网网囊系统水动力及渔获性能的调控机制
- 批准号:32373187
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
The role of youth voluntary actions in Disaster Risk Reduction in the Ganges Brahmaputra and Meghna (GBM) delta
青年志愿行动在雅鲁藏布江和梅格纳河三角洲减少灾害风险中的作用
- 批准号:
2593674 - 财政年份:2025
- 资助金额:
$ 105.18万 - 项目类别:
Studentship
Modulating H2O Activity Promotes CO2 Reduction to Multi-Carbon Products
调节 H2O 活性可促进多碳产品的 CO2 还原
- 批准号:
2326720 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
- 批准号:
2348457 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Standard Grant
Contorted and Strained Molecular Nanographenes: Multi-Electron Storage and Reduction-Induced Transformations
扭曲和应变的分子纳米石墨烯:多电子存储和还原诱导的转变
- 批准号:
2404031 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Continuing Grant
Noise-reduction mechanisms in jet engines: chevrons are the answer
喷气发动机的降噪机制:人字形就是答案
- 批准号:
DE240100933 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Discovery Early Career Researcher Award
Model order reduction for fast phase-field fracture simulations
快速相场断裂模拟的模型降阶
- 批准号:
EP/Y002474/1 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Research Grant
CAS:Improving the Activity of Homogeneous Mn Catalysts for the Oxygen Reduction Reaction
CAS:提高均相锰催化剂的氧还原反应活性
- 批准号:
2348515 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Standard Grant
Probing Electrochemical Interface in CO2 reduction by Operando Computation
通过操作计算探测二氧化碳还原中的电化学界面
- 批准号:
DE240100846 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Discovery Early Career Researcher Award
Multimetallic CO2 Reduction Catalysts as Artificial Cofactors
作为人工辅助因子的多金属二氧化碳还原催化剂
- 批准号:
EP/Y002695/1 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Research Grant
Effect of Reynolds number on drag reduction: from near-wall cycle to large-scale motions.
雷诺数对减阻的影响:从近壁循环到大规模运动。
- 批准号:
2345157 - 财政年份:2024
- 资助金额:
$ 105.18万 - 项目类别:
Standard Grant